BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2581383)

  • 1. [Pharmacology of astemizole (Hismanal) a non-sedating H1 antihistaminic].
    Niemegeers CJ
    Z Hautkr; 1985; 60 Suppl 1():14-22. PubMed ID: 2581383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiallergic effects of astemizole on immediate type hypersensitivity reactions.
    Tasaka K; Akagi M; Izushi K; Mio M
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):531-9. PubMed ID: 1709434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound.
    Van Wauwe J; Awouters F; Neimegeers CJ; Janssens F; Van Nueten JM; Janssen PA
    Arch Int Pharmacodyn Ther; 1981 May; 251(1):39-51. PubMed ID: 6114717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological profile of a specific, safe, effective and non-sedative anti-allergic, astemizole.
    Niemegeers CJ; Awouters F; Janssen PA
    Agents Actions; 1986 Apr; 18(1-2):141-4. PubMed ID: 2873722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [General review of a non-sedative antihistaminic, astemizole (Hismanal), a H1 receptor antagonist].
    Molkhou P
    Allerg Immunol (Paris); 1988 May; 20(5):197-201. PubMed ID: 2900641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
    Fügner A; Bechtel WD; Kuhn FJ; Mierau J
    Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of E-4716, a new antihistaminic with antiallergic properties, on chemical mediators induction of immunologic reactions.
    Gutiérrez B; Dordal A; Fort M; Galicia J; Farré AJ
    Methods Find Exp Clin Pharmacol; 1996; 18(6):397-406. PubMed ID: 8892269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of the specific histamine H1-antagonist astemizole.
    Awouters FH; Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1983; 33(3):381-8. PubMed ID: 6135428
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro and in vivo binding characteristics of a new long-acting histamine H1 antagonist, astemizole.
    Laduron PM; Janssen PF; Gommeren W; Leysen JE
    Mol Pharmacol; 1982 Mar; 21(2):294-300. PubMed ID: 6124876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of interaction between the H1-antagonist astemizole and other drugs.
    Rombaut N; Heykants J; Vanden Bussche G
    Ann Allergy; 1986 Nov; 57(5):321-4. PubMed ID: 2877601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Astemizole: its pharmacokinetics and pharmacologic properties].
    Levron JC; Gillardin JM; Sabbah A
    Allerg Immunol (Paris); 1990 Jun; 22(6):233-41. PubMed ID: 1974137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hismanal--a non-sedating H1 antihistaminic].
    Karrass W
    Z Hautkr; 1985; 60 Suppl 1():59-66. PubMed ID: 2859716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-sedative antihistaminics and binding to central and peripheral H1 histamine receptors].
    Leysen JE; Gommeren W; Janssen PF; Sanz G; Gillardin JM; Schotte A; Janssen PA
    Allerg Immunol (Paris); 1991 Feb; 23(2):51-7. PubMed ID: 1677249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-anaphylactic activity of the novel selective histamine H1 receptor antagonist mizolastine in the rodent.
    Levrier J; Duval D; Prouteau M; Voltz C; Berry CN; Lloyd KG; Scatton B
    Arzneimittelforschung; 1995 May; 45(5):559-68. PubMed ID: 7541995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy.
    Richards DM; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Jul; 28(1):38-61. PubMed ID: 6204835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiallergic effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)benzimidaz ole difumarate (KB-2413).
    Fukuda T; Saito T; Tajima S; Shimohara K; Ito K
    Arzneimittelforschung; 1984; 34(7):805-10. PubMed ID: 6208915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tecastemizole on pulmonary and cutaneous allergic inflammatory responses.
    Lever R; Hefni A; Moffatt JD; Paul W; Page CP
    Clin Exp Allergy; 2007 Jun; 37(6):909-17. PubMed ID: 17517105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs.
    Kamei C; Mio M; Izushi K; Kitazumi K; Tsujimoto S; Fujisawa K; Adachi Y; Tasaka K
    Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
    Benavides J; Schoemaker H; Dana C; Claustre Y; Delahaye M; Prouteau M; Manoury P; Allen J; Scatton B; Langer SZ
    Arzneimittelforschung; 1995 May; 45(5):551-8. PubMed ID: 7612054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.